Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Coronary artery disease

Recruiting

Registered drugNo placebo

Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Adenosine

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Divarasib

Contact Research Centre

Dermatitis atopic

Recruiting

Registered drug

Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Recruiting

Registered drugNo placebo

Study of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Obesity

Recruiting

Investigational

Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Hypereosinophilic syndrome+1

Recruiting

Registered drugNo placebo

Study of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Benralizumab

Contact Research Centre

Multiple sclerosis

Recruiting

InvestigationalNo placebo

Safety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis

InvestigationalNo placebo

Poland

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Hodgkin's disease

Recruiting

Registered drugNo placebo

Study of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Brentuximab Vedotin

Contact Research Centre

Neurodermatitis

Recruiting

Investigational

ICP-332 for Adults with Prurigo Nodularis

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Graves' disease

Recruiting

InvestigationalNo placebo

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

Find therapies in clinical trials near you – page 2

184 trials match your criteria

Coronary artery disease

Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

Type 2 diabetes mellitus

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Non-small cell lung cancer

Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

Dermatitis atopic

Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Type 2 diabetes mellitus

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Hormone receptor positive HER2 negative breast cancer

Study of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer

Obesity

Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

Hypereosinophilic syndrome+1

Study of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease

Multiple sclerosis

Safety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis

Hodgkin's disease

Study of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma

Neurodermatitis

ICP-332 for Adults with Prurigo Nodularis

Graves' disease

Long-Term Study of Imeroprubart in Adults With Graves' Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.